Sodium cromoglycate therapy in wheezing infants: Preliminary evidence of beneficial outcome at early school age

Pediatrics International

Volumn 47, Issue 6, 2005, Pages 627-634

  Kotaniemi Syrjänen, Anne ^a   Reijonen, Tiina M ^a   Korhonen, Kaj ^a   Korppi, Matti ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Asthma; Budesonide; Infant; Sodium cromoglycate; Wheezing

Indexed keywords

BUDESONIDE; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; ATOPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; FINLAND; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEBULIZER; OPEN STUDY; PRESCHOOL CHILD; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SENSITIVITY ANALYSIS; UNIVERSITY HOSPITAL; WHEEZING; ABNORMAL RESPIRATORY SOUND; CHILD; INFANT; TREATMENT OUTCOME;

ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BUDESONIDE; CHILD; CROMOLYN SODIUM; FOLLOW-UP STUDIES; HUMANS; INFANT; RESPIRATORY SOUNDS; TREATMENT OUTCOME;

EID: 33644876997     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2005.02147.x     Document Type: Article

References (35)

1. Geller-Benstein C, Levin S. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children. Respiration 1982 43 : 294 8.
2. Bertelsen A, Andersen JB, Busch P et al. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. Allergy 1986 41 : 266 70.
3. Furfaro S, Sheldon S, Drblik SP, Turgeon JP, Robert M. Efficacy of cromoglycate in persistently wheezing infants. Arch. Dis. Child 1994 71 : 331 4.
4. Carlsen KH, Leegaard J, Larsen S, Ørstavik I. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch. Dis. Child 1988 63 : 1428 33.
5. Chavasse RJ, Bastian-Lee Y, Richter H, Hilliard T, Seddon P. Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone. Arch. Dis. Child 2001 85 : 143 8.
6. Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J. Pediatr. 1998 132 : 849 53.
7. Wong JYW, Moon S, Beardsmore C, O'Callaghan C, Simpson H. No objective benefit from steroids inhaled via a spacer in infants recovering from bronchiolitis. Eur. Respir. J. 2000 15 : 388 94.
8. Fox GF, Everard ML, Marsh MJ, Milner AD. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch. Dis. Child 1999 80 : 343 7.
9. Kajosaari M, Syvänen P, Förars M, Juntunen-Backman K. Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma. Pediatr. Allergy Immunol. 2000 11 : 198 202.
10. Lødrup Carlsen KC, Carlsen KH, Nikander K et al. Nebulized budesonide after hospitalization for recurrent bronchial obstruction in children younger than 18 months. Pediatr. Allergy Immunol. 2001 12 : 159 65.
11. Reijonen T, Korppi M, Kuikka L, Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch. Pediatr. Adolesc. Med. 1996 150 : 512 17.
12. Reijonen TM. Early Childhood Wheezing. A Study on Therapy and Risk Factors for Recurrent Bronchial Obstructions. Kuopio University Printing Office, Kuopio, 1997.
13. Reijonen TM, Korppi M. One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma. Pediatr. Pulmonol. 1998 26 : 113 19.
14. Reijonen TM, Kotaniemi-Syrjänen A, Korhonen K, Korppi M. Predictors of asthma three years after hospital admission for wheezing in infancy. Pediatrics 2000 106 : 1406 11.
15. Kotaniemi-Syrjänen A, Reijonen TM, Korhonen K, Korppi M. Wheezing requiring hospitalization in early childhood: predictive factors for asthma in a 6-year follow-up. Pediatr. Allergy Immunol. 2002 13 : 418 25.
16. Remes S, Korppi M, Remes K, Pekkanen J. Prevalence of asthma at school age: a clinical population-based study in eastern Finland. Acta Paediatr. 1996 85 : 59 63.
17. Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M. Differential immune responses to acute lower respiratory illness in early life and subsequent development of persistent wheezing and asthma. J. Allergy Clin. Immunol. 1998 102 : 915 20.
18. Church MK, Hutson PA, Holgate ST. Effect of nedocromil sodium on early and late responses to allergen challenge in the guinea-pig. Drugs 1989 37 (Suppl. 1 101 8.
19. Busse WW, Lemanske RF Jr. Advances in immunology: asthma. N. Engl. J. Med. 2001 344 : 350 62.
20. Szefler SJ. Glucocorticoid therapy for asthma: clinical pharmacology. J. Allergy Clin. Immunol. 1991 88 : 147 64.
21. Friedman BS, Bell EH, Buntix A. Oral leukotriene inhibitor (MK-866) blocks allergen induced airway responses. Am. Rev. Respir. Dis. 1993 147 : 839 44.
22. Kimata H, Yoshida A, Ishioka C, Mikawa H. Disodium cromoglycate (DSCG) selectively inhibits IgE production and enhances IgG4 production by human B cells in vitro. Clin. Exp. Immunol. 1991 84 : 395 9.
23. Loh RK, Jabara HH, Geha RS. Cromolyn sodium (CS) and nedocromil sodium (NS) inhibit Su-Sg deletional switch recombination and IgE synthesis in human B cells. J. Allergy Clin. Immunol. 1994 93 : 219 (abstract).
24. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N. Engl. J. Med. 1995 332 : 133 8.
25. Stevenson EC, Turner G, Heaney LG. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin. Exp. Allergy 1997 9 : 1027 35.
26. Newth CJL, Newth CV, Turner JAP. Comparison of nebulised sodium cromoglycate and oral theophylline in controlling symptoms of chronic asthma in pre-school children: a double blind study. Aust. NZ. J. Med. 1982 12 : 232 8.
27. Henry RL, Hiller EJ, Milner AD, Hodges IGC, Stokes GM. Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life. Arch. Dis. Child. 1984 59 : 54 7.
28. Cogswell JJ, Simpkiss MJ. Nebulised sodium cromoglycate in recurrently wheezy preschool children. Arch. Dis. Child. 1985 60 : 736 8.
29. Tasche MJ, van der Wouden JC, Uijen JH et al. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. Lancet 1997 350 : 1060 4.
30. Maayan C, Itzhaki T, Bar-Yishay E, Gross S, Tal A, Godfrey S. The functional response of infants with persistent wheezing to nebulized beclomethasone dipropionate. Pediatr. Pulmonol. 1986 2 : 9 14.
31. Noble V, Ruggins NR, Everard ML, Milner AD. Inhaled budesonide for chronic wheezing under 18 months of age. Arch. Dis. Child. 1992 67 : 285 8.
32. Bisgaard H, Munck SL, Nielsen JP, Petersen W, Ohlsson SV. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990 336 : 649 51.
33. Stick SM, Burton PR, Clough JB, Cox M, LeSouëf PN, Sly PD. The effects of inhaled beclomethasone dipropionate on lung function and histamine responsiveness in recurrently wheezy infants. Arch. Dis. Child 1995 73 : 327 32.
34. Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch. Dis. Child 1995 72 : 317 20.
35. Kraemer R, Graf Bigler U, Casaulta Aebischer C, Weder M, Birrer P. Clinical and physiological improvement after inhalation of low-dose beclomethasone dipropionate and salbutamol in wheezy infants. Respiration 1997 64 : 342 9.